Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Collagen networks play a key role in hair loss and follicle miniaturization.

Skin aging can be slowed by targeting cells, hormones, and the microbiome.

Upadacitinib effectively treats psoriasis and lichen planus together.

Improving oral health may help hair regrowth in children with alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

FFA has higher long-term remission rates than LPP.

Rituximab can cause skin issues, but baricitinib may help improve them.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

A tailored treatment improved a Pomeranian dog's skin and hair issues caused by a vaccine.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Superoxide dismutases help balance cell stress and may aid cancer treatment.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Stem cells show promise for hair regrowth, but challenges remain.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Lichen planopilaris can occur with multiple autoimmune diseases.

Innate lymphoid cells help us understand and manage allergic diseases better.